Awareness of Osteoporosis in HIV Patients

Osteoporosis Clinical Trial

Official title: Awareness of Osteoporosis in HIV Patients

Status Not yet recruiting

Clinical Trial Summary

Osteoporosis is a condition that describes compromised skeletal microarchitecture in general, with clinical signs of decreased bone mineral density. Patients with human immunodeficiency virus infection are at increased risk for developing osteoporosis. Identifying whether patients with human immunodeficiency virus infection have information and awareness about this disease is crucial. This study is aimed to investigate awareness and knowledge of osteoporosis in patients with human immunodeficiency virus infection.

Clinical Trial Description

Osteoporosis is a common disease of bone loss. The reduced bone strength predisposes an increased risk for fractures in older individuals. It can affect people from different ethnicity. Many factors increase the risk of osteoporosis, including age, postmenopausal state, glucocorticoid use, low body weight, calcium, vitamin D, immobility, and chronic inflammation. Patients with human immunodeficiency virus infection are at high risk of developing osteoporosis due to chronic inflammation and their medications. Patients' knowledge and awareness about osteoporosis are essential for early detection, implementation of lifestyle changes, and treatment compliance. This study aimed to investigate osteoporosis awareness and knowledge about osteoporosis in patients with human immunodeficiency virus infection. ;

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• HIV Infections
• Human Immunodeficiency Virus Infection
• Osteoporosis
• Osteoporosis Risk

• NCT number: NCT05769413
• Study type: Observational [Patient Registry]
• Source: Uskudar State Hospital
• Contact: Mustafa H Temel, M.D.
• Phone: +905342714872
• Email: mhuseyintemel@gmail.com
• Status: Not yet recruiting
• Start date: August 1, 2023
• Completion date: August 1, 2024